Literature DB >> 32492105

A Randomized Trial of Convalescent Plasma for COVID-19-Potentially Hopeful Signals.

Arturo Casadevall1, Michael J Joyner2, Liise-Anne Pirofski3.   

Abstract

Entities:  

Mesh：

Year:  2020        PMID： 32492105     DOI： 10.1001/jama.2020.10218

Source DB:  PubMed          Journal:  JAMA        ISSN： 0098-7484            Impact factor:   56.272


× No keyword cloud information.
  32 in total

1.  Dynamics of antibodies to SARS-CoV-2 in convalescent plasma donors.

Authors:  Maurice Steenhuis; Gerard van Mierlo; Ninotska Il Derksen; Pleuni Ooijevaar-de Heer; Simone Kruithof; Floris L Loeff; Lea C Berkhout; Federica Linty; Chantal Reusken; Johan Reimerink; Boris Hogema; Hans Zaaijer; Leo van de Watering; Francis Swaneveld; Marit J van Gils; Berend Jan Bosch; S Marieke van Ham; Anja Ten Brinke; Gestur Vidarsson; Ellen C van der Schoot; Theo Rispens
Journal:  Clin Transl Immunology       Date:  2021-05-16

2.  Convalescent Plasma for the Prevention and Treatment of COVID-19: A Systematic Review and Quantitative Analysis.

Authors:  Henry T Peng; Shawn G Rhind; Andrew Beckett
Journal:  JMIR Public Health Surveill       Date:  2021-04-07

Review 3.  Pathogenesis of COVID-19 from the Perspective of the Damage-Response Framework.

Authors:  Liise-Anne Pirofski; Arturo Casadevall
Journal:  mBio       Date:  2020-07-02       Impact factor: 7.867

4.  Hospitalized COVID-19 Patients treated with Convalescent Plasma in a Mid-size City in the Midwest.

Authors:  William R Hartman; Aaron S Hess; Joseph P Connor
Journal:  Res Sq       Date:  2020-07-14

Review 5.  Convalescent Plasma Therapy for Management of COVID-19: Perspectives and Deployment in the Current Global Pandemic.

Authors:  Nandeeta Samad; Temitayo Eniola Sodunke; Hasan Al Banna; Ashmita Sapkota; Aneeka Nawar Fatema; Katia Iskandar; Dilshad Jahan; Timothy Craig Hardcastle; Tanzina Nusrat; Tajkera Sultana Chowdhury; Mainul Haque
Journal:  Risk Manag Healthc Policy       Date:  2020-11-23

6.  Convalescent plasma therapy: Helpful treatment of COVID-19 in a kidney transplant recipient presenting with severe clinical manifestations and complex complications.

Authors:  Jipin Jiang; Yan Miao; Yuanyuan Zhao; Xia Lu; Ping Zhou; Xiaojun Zhou; Zhishui Chen; Dunfeng Du
Journal:  Clin Transplant       Date:  2020-07-15       Impact factor: 3.456

Review 7.  Erythropoietin as candidate for supportive treatment of severe COVID-19.

Authors:  Hannelore Ehrenreich; Karin Weissenborn; Martin Begemann; Markus Busch; Eduard Vieta; Kamilla W Miskowiak
Journal:  Mol Med       Date:  2020-06-16       Impact factor: 6.354

8.  Analysis of the SARS-CoV-2 spike protein glycan shield reveals implications for immune recognition.

Authors:  Oliver C Grant; David Montgomery; Keigo Ito; Robert J Woods
Journal:  Sci Rep       Date:  2020-09-14       Impact factor: 4.379

9.  Compassionate use of convalescent plasma for treatment of moderate and severe pneumonia in COVID-19 patients and association with IgG antibody levels in donated plasma.

Authors:  Yasmin Maor; Daniel Cohen; Nir Paran; Tomer Israely; Vered Ezra; Ofra Axelrod; Eilat Shinar; Marina Izak; Galia Rahav; Naomi Rahimi-Levene; Baruch M Bazofin; Ram Gelman; Dror Dicker; Tal Brosh-Nissimov; Orli Megged; David Dahan; Avi Benov; Alona Paz; Kaykov Edward; Amit Moran; Ori Rogowski; Patrick Sorkine; Ami Mayo; Oren Zimhony; Jacob Chen
Journal:  EClinicalMedicine       Date:  2020-09-09

10.  MEK inhibitors reduce cellular expression of ACE2, pERK, pRb while stimulating NK-mediated cytotoxicity and attenuating inflammatory cytokines relevant to SARS-CoV-2 infection.

Authors:  Lanlan Zhou; Kelsey Huntington; Shengliang Zhang; Lindsey Carlsen; Eui-Young So; Cassandra Parker; Ilyas Sahin; Howard Safran; Suchitra Kamle; Chang-Min Lee; Chun Geun Lee; Jack A Elias; Kerry S Campbell; Mandar T Naik; Walter J Atwood; Emile Youssef; Jonathan A Pachter; Arunasalam Navaraj; Attila A Seyhan; Olin Liang; Wafik S El-Deiry
Journal:  Oncotarget       Date:  2020-11-17
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.